Patent · US Active

Compounds and compositions as TLR activity modulators

US9045470B2 · kind B2 · utility

13Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2010
Grant dateJun 2, 2015
Priority date
Expiry dateAug 25, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a novel class of compounds, immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with Toll-Like Receptors 7. In one aspect, the compounds are useful as adjuvants for enhancing the effectiveness of a vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.